LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 345 filers reported holding LIGAND PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 0.67 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $326,000 | +9.4% | 2,852 | +20.2% | 0.37% | +6.1% |
| Q1 2019 | $298,000 | -2.3% | 2,372 | +5.5% | 0.34% | -15.6% |
| Q4 2018 | $305,000 | -36.1% | 2,249 | +29.6% | 0.41% | -13.2% |
| Q3 2018 | $477,000 | +13.3% | 1,736 | -14.7% | 0.47% | +24.3% |
| Q2 2018 | $421,000 | -6.9% | 2,034 | -25.7% | 0.38% | -8.0% |
| Q1 2018 | $452,000 | +10.2% | 2,737 | +5.2% | 0.41% | +33.3% |
| Q4 2017 | $410,000 | +8.5% | 2,602 | -0.1% | 0.31% | +7.7% |
| Q3 2017 | $378,000 | +7.7% | 2,604 | -9.9% | 0.29% | +9.1% |
| Q2 2017 | $351,000 | +41.0% | 2,891 | +22.9% | 0.26% | +27.7% |
| Q1 2017 | $249,000 | – | 2,353 | – | 0.21% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knott David M Jr | 115,000 | $6,891 | 2.63% |
| VILLERE ST DENIS J & CO LLC | 438,161 | $26,254,607 | 2.24% |
| RICE HALL JAMES & ASSOCIATES, LLC | 282,961 | $16,955,023 | 1.08% |
| Chicago Capital, LLC | 360,345 | $21,591,884 | 1.01% |
| CARDINAL CAPITAL MANAGEMENT LLC /CT | 206,399 | $12,367,428 | 0.53% |
| Smith, Graham & Co., Investment Advisors, LP | 61,849 | $3,705,992 | 0.46% |
| Stephens Investment Management Group LLC | 467,564 | $28,016,435 | 0.46% |
| Jackson Creek Investment Advisors LLC | 13,657 | $818 | 0.34% |
| Court Place Advisors, LLC | 15,133 | $906,769 | 0.32% |
| Ziegler Capital Management, LLC | 123,158 | $7,379,176 | 0.30% |